查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466444

猪源疫苗市场：按适应症、技术、最终用户划分 - 2024-2030 年全球预测

Porcine Vaccines Market by Indication (Arthritis, Diarrhea, Porcine Circovirus Associated Disease), Technology (Conjugate Vaccines, DNA Vaccines, Inactivated Vaccines), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年猪源疫苗市场规模为17.1亿美元，预计2024年将达18.2亿美元，2030年将达27亿美元，复合年增长率为6.72%。

猪源疫苗是预防猪多种疾病的免疫製剂。这些疫苗的目的是刺激猪的免疫系统并增强对引起疾病的病毒和细菌等病原体的防御能力。透过模仿感染，猪的身体准备好识别并对抗未来遇到的真正病原体。猪隻病发生率的增加和全球猪肉产品消费量的增加是对猪源疫苗需求的主要驱动力。此外，补贴和宣传计划等政府支持措施正在促进疫苗的使用。然而，对低温运输基础设施的需求带来了物流挑战，特别是在开发中国家。此外，猪品种之间免疫反应的差异可能会影响疫苗的功效，并为猪源疫苗的开发和引进带来障碍。然而，主要参与者正在探索奈米技术、基因编辑策略和精准医学等新技术，以确保开发出能够克服猪源疫苗性能挑战的客製化疫苗。此外，对在不影响安全性的情况下增强免疫反应的新佐剂的研究以及无针注射方法的开发可以提高疫苗的吸收并减少对动物的压力。

主要市场统计
基准年[2023] 17.1亿美元
预测年份 [2024] 18.2亿美元
预测年份 [2030] 27亿美元
复合年增长率（%） 6.72%

技术 基因工程和分子生物学技术的进步将推动重组疫苗的创新。

结合疫苗是多醣抗原与载体分子融合或连接的疫苗。猪源疫苗一般用于针对病原体含有多醣的疾病，其免疫抗原性较低。当针对由带有多醣胶囊的细菌引起的疾病时，此类疫苗特别有用。 DNA 疫苗利用遗传物质来诱发免疫反应。一旦遗传物质进入动物细胞，它就会被用来产生抗原，刺激免疫系统。这些疫苗对于兽医领域来说仍然相对较新。此类疫苗可能是优选的，因为它们可以快速开发并且可以提供长期免疫力而不需要佐剂。灭活疫苗含有杀死的病原体。它不会引起感染疾病，但会引起免疫反应。这些疫苗被认为是安全且稳定的。减毒活病毒疫苗是活的减毒病原体。它非常模仿自然感染，通常提供强大、持久的免疫力。重组疫苗使用透过基因工程技术创建的病原体的部分（通常是蛋白质）。该成分用于刺激免疫反应，而不存在引入活病原体的风险。类毒素疫苗是透过灭活某些细菌产生的毒素而製成的。这些疫苗用于预防由细菌产生的毒素引起的疾病，而不是细菌本身。在处理主要由细菌毒素引起的疾病时，类毒素疫苗是首选。

最终用户：养猪场大规模疫苗接种计画的需求不断增加

生猪/生猪养殖场部门包括主要从事肉类生产生猪饲养的营业单位。这些农场对疫苗的需求是为了维持无疾病的环境、提高牲畜生长表现并最终提高农民的盈利。生猪和养猪场通常需要涵盖多种常见猪病的疫苗，包括猪繁殖与呼吸综合症 (PRRS)、猪流感和口蹄疫。兽医医院和诊所治疗各种动物，包括猪。作为常规健康检查或特定疾病爆发的一部分，这些设施通常会遇到猪和其他猪进行疫苗接种。在这种环境下，首选具有广泛功效和快速产生免疫力的疫苗。由于这些设施针对的是个人或小群体，因此他们通常更喜欢单剂量、更易于管理或包装尺寸较小的疫苗。

区域洞察

美洲，特别是美国和加拿大，由于其大型养猪场和对动物健康管理的重视，拥有完善的猪疫苗市场。该国消费者对猪隻繁殖与呼吸综合症（PRRS）和猪流感等地方性疾病疫苗接种的需求很高。生产者经常采用最新的疫苗，他们的购买行为表明他们愿意为猪群投资先进的解决方案。美国的研究最近集中在开发更有效、提供更长时间免疫力的疫苗。对生物技术公司和美国农业部动植物卫生检验局 (APHIS) 兽医生物製品计划等政府生技药品的投资将继续加强该行业，这反映了我们的努力。欧洲、中东和非洲国家是多元化的市场，有严格的动物福利和卫生法规。欧洲消费者要求符合高安全标准的疫苗，从而增加了对有品质保证的疫苗的需求。欧盟的地平线 2020 计画正在大力投资猪病研究，这有助于开发新的高效疫苗。在亚太地区，中国猪肉市场高度发达，增加了对猪肉市场的需求。在亚太地区生猪养殖业蓬勃发展的印度，对猪源疫苗的需求正在增加，儘管成长幅度不大。消费者的需求围绕着负担得起且可用的疫苗，以及对成本敏感的购买行为。政府正在透过支持疫苗接种和动物健康计划的措施来鼓励养猪业的发展。

FPNV定位矩阵

FPNV定位矩阵对于评估猪源疫苗市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对猪隻疫苗市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争力评估及资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.猪源疫苗市场规模及预测如何？

2.在猪疫苗市场预测期间内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.猪源疫苗市场的技术趋势与法规结构是什么？

4.猪源疫苗市场主要厂商的市场占有率如何？

5. 进入猪源疫苗市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地猪病流行率不断上升
      • 对优质猪肉的需求增加
      • 政府支持动物健康的倡议
    • 抑制因素
      • 猪疫苗研发高成本、储存复杂
    • 机会
      • 猪疫苗的技术进步
      • 投资情势有利于新型猪源疫苗生产
    • 任务
      • 猪源疫苗的可得性和认知度有限，且有副作用
  • 市场区隔分析
    • 技术：基因工程和分子生物学技术的进步推动重组疫苗的创新
    • 最终用户：生猪养殖场大规模疫苗接种计画的需求不断增加
  • 市场趋势分析
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化

第六章 猪源疫苗市场适应症

  • 关节炎
  • 腹泻
  • 猪环状病毒相关疾病
  • 猪繁殖与呼吸综合症
  • 猪流感

第七章猪源疫苗市场：依技术分类

  • 结合疫苗
  • DNA疫苗
  • 灭活疫苗
  • 减毒活疫苗
  • 重组疫苗
  • 类毒素疫苗

第八章猪源疫苗市场：依最终用户分类

  • 养猪场
  • 兽医诊所/医院

第九章 南北美洲猪源疫苗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太猪源疫苗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲猪源疫苗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • Zoetis 在英国推出 Circomax
    • 默克动物保健推出三合一猪疫苗
    • Elanco 是 Aptimmune 的 PRRS 灭活自体疫苗的美国独家经销商

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-742BD5183CF6

[185 Pages Report] The Porcine Vaccines Market size was estimated at USD 1.71 billion in 2023 and expected to reach USD 1.82 billion in 2024, at a CAGR 6.72% to reach USD 2.70 billion by 2030.

Porcine vaccines are immunological preparations designed to prevent various swine diseases in pigs. These vaccines are created to stimulate the porcine immune system, enabling it to develop defenses against pathogens such as viruses or bacteria that can cause illness. By mimicking the infection, they prepare the swine's body to recognize and combat the actual pathogens should they be encountered in the future. The rise in the incidence of swine diseases and the growing global consumption of pork products are major driving factors behind the need for porcine vaccines. Furthermore, supportive government initiatives, including subsidies and awareness programs, have encouraged the use of vaccines. However, the need for a cold chain infrastructure creates logistical challenges, particularly in developing countries. Furthermore, the variability in the immune response of different pig breeds can impact vaccine effectiveness and create hurdles for the development and adoption of porcine vaccines. However, key players are exploring novel technologies such as nanotechnology, gene editing strategies, and precision medicine to ensure the development of customized vaccines that can overcome the performance challenges of porcine vaccines. Moreover, investigating new adjuvants to enhance immune response without compromising safety and developing needle-free administration could improve vaccine uptake and reduce stress on animals.

KEY MARKET STATISTICS
Base Year [2023] USD 1.71 billion
Estimated Year [2024] USD 1.82 billion
Forecast Year [2030] USD 2.70 billion
CAGR (%) 6.72%

Technology: Growing innovations in recombinant vaccines due to advancements in genetic engineering and molecular biology technologies

A conjugate vaccine refers to a vaccine that is composed of a polysaccharide antigen fused or conjugated to a carrier molecule. In porcine vaccines, they are used to target diseases where the pathogens have polysaccharide coatings, which are generally poorly immunogenic. Such vaccines are especially useful for targeting diseases caused by bacteria with polysaccharide capsules. DNA vaccines utilize genetic material to induce an immune response. When the genetic material enters the animal's cells, it is used to produce the antigen which in turn stimulates the immune system. These vaccines are still relatively novel in the veterinary field. Such vaccines may be preferred for their potential for rapid development and their ability to provide long-lasting immunity without the need for adjuvants. Inactivated vaccines contain pathogens that have been killed. They cannot cause an infection but still prompt an immune response. These vaccines are considered safe and stable. Live attenuated vaccines contain a live and weakened version of the pathogen. They closely mimic a natural infection and typically provide strong, long-lasting immunity. Recombinant vaccines use a piece of the pathogen (typically a protein) created using the techniques of genetic engineering. This component is used to stimulate an immune response without the risk of introducing a live pathogen. Toxoid vaccines are created by inactivating the toxins produced by certain bacteria. These vaccines are used to protect against diseases that are caused not by the bacteria itself, but by the toxins they produce. Toxoid vaccines are the preferred option when addressing illnesses where the primary concern is the bacterial toxin.

End User: Growing need for mass vaccination programs in the hog/pig production farm

The hog/pig production farm sector includes entities involved in raising pigs primarily for meat production. The need for vaccines in such farms is driven by the requirement to maintain a disease-free environment, enhance growth performance of the animals, and ultimately increase farmer profitability. Hog and pig production farms typically require vaccines thar can address a wide spectrum of common swine diseases, such as porcine reproductive and respiratory syndrome (PRRS), swine influenza, and foot and mouth disease, among others. Veterinary clinics and hospitals cater to a broad range of animals, including pigs. These facilities generally encounter pigs and other swine for vaccinations as part of routine health checks or specific disease outbreaks. The vaccine preferences in this environment are for products with broad-spectrum efficacy and rapid onset of immunity. Since these facilities might be dealing with individual animals or small herds, they often prefer single-dose, easy-to-administer vaccines that are also available in smaller package sizes.

Regional Insights

In the Americas region, particularly the U.S. and Canada, the porcine vaccine market is well-established due to the extensive pig farming industry and a strong emphasis on animal health management. The country sees a significant consumer need for vaccinations against prevalent diseases such as porcine reproductive and respiratory syndrome (PRRS), swine influenza, and others. Producers often adopt the latest vaccines, and purchasing behavior indicates a readiness to invest in advanced solutions for swine herds. Recent research in the U.S. has focused on developing vaccines with improved efficacy and longer immunity periods. Investments in biotechnology companies and government initiatives such as the Veterinary Biologics Program under the United States Department of Agriculture(USDA)-Animal & Plant Health Inspection Service(APHIS) reflect ongoing efforts to strengthen the sector. The EMEA countries represent a diverse market with stringent animal welfare and health regulations. The European consumer requires vaccines that comply with high safety standards, leading to a demand for quality-assured vaccines. The EU's Horizon 2020 program has seen substantial investments in research addressing swine diseases, which propels the development of new and efficient vaccines. In the APAC region, China represents a highly evolved market for pig meat, thereby accentuating the need for porcine markets. India, with an emerging pig farming industry in the APAC region, presents a moderate but growing demand for porcine vaccines. Consumer needs revolve around affordable and accessible vaccines due to cost-sensitive purchasing behaviors. The government has been encouraging the growth of the swine industry through initiatives that provide support for vaccinations and animal health programs.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Porcine Vaccines Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Porcine Vaccines Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Porcine Vaccines Market, highlighting leading vendors and their innovative profiles. These include Aptimmune Biologics, Inc., Arko Laboratories, AVAC Vietnam Joint Stock Company, Bayer AG, Bimeda Holdings PLC, Biogenesis Bago S.A., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Eli Lilly and Company, Endovac Animal Health, FATRO S.p.A., Formosa Biomedical Inc., Genvax Technologies, Inc., HIPRA, S.A., Indian Immunologicals Ltd., KM Biologics Co., Ltd., Kyoto Biken Laboratories, Inc., Malaysian Vaccines & Pharmaceuticals Sdn Bhd., Medgene Labs, Merck & Co., Inc., Nisseiken Co., Ltd., PBS Animal Health, Phibro Animal Health Corporation, Virbac SA, Yenher Agro-Products Sdn. Bhd., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Porcine Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Arthritis
    • Diarrhea
    • Porcine Circovirus Associated Disease
    • Porcine Reproductive & Respiratory Syndrome
    • Swine Influenza
  • Technology
    • Conjugate Vaccines
    • DNA Vaccines
    • Inactivated Vaccines
    • Live attenuated Vaccines
    • Recombinant Vaccines
    • Toxoid Vaccines
  • End User
    • Hog/Pig Production Farm
    • Veterinary Clinics/Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Porcine Vaccines Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Porcine Vaccines Market?

3. What are the technology trends and regulatory frameworks in the Porcine Vaccines Market?

4. What is the market share of the leading vendors in the Porcine Vaccines Market?

5. Which modes and strategic moves are suitable for entering the Porcine Vaccines Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in Prevalence of Swine Diseases Worldwide
      • 5.1.1.2. Increasing Demand for High-Quality Pork Meat
      • 5.1.1.3. Government Initiatives to Support Animal Health
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of Porcine Vaccine Development and Complex Storage Issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements in Porcine Vaccine
      • 5.1.3.2. Favorable Investment Landscape For Production of Novel Porcine Vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Limited Availability and Awareness Along with Side Effects Associated with Porcine Vaccines
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Growing innovations in recombinant vaccines due to advancements in genetic engineering and molecular biology technologies
    • 5.2.2. End User: Growing need for mass vaccination programs in the hog/pig production farm
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Porcine Vaccines Market, by Indication

  • 6.1. Introduction
  • 6.2. Arthritis
  • 6.3. Diarrhea
  • 6.4. Porcine Circovirus Associated Disease
  • 6.5. Porcine Reproductive & Respiratory Syndrome
  • 6.6. Swine Influenza

7. Porcine Vaccines Market, by Technology

  • 7.1. Introduction
  • 7.2. Conjugate Vaccines
  • 7.3. DNA Vaccines
  • 7.4. Inactivated Vaccines
  • 7.5. Live attenuated Vaccines
  • 7.6. Recombinant Vaccines
  • 7.7. Toxoid Vaccines

8. Porcine Vaccines Market, by End User

  • 8.1. Introduction
  • 8.2. Hog/Pig Production Farm
  • 8.3. Veterinary Clinics/Hospitals

9. Americas Porcine Vaccines Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Porcine Vaccines Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Porcine Vaccines Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Zoetis Launches Circomax In The UK
    • 12.3.2. Merck Animal Health Launches 3-In-One Swine Vaccine
    • 12.3.3. Elanco is Exclusive U.S. Distributor of Aptimmune's PRRS Killed Autogenous Vaccine

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. PORCINE VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. PORCINE VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PORCINE VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PORCINE VACCINES MARKET DYNAMICS
  • FIGURE 7. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. PORCINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. PORCINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PORCINE VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PORCINE VACCINES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL PORCINE VACCINES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL PORCINE VACCINES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL PORCINE VACCINES MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL PORCINE VACCINES MARKET SIZE, BY ARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL PORCINE VACCINES MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL PORCINE VACCINES MARKET SIZE, BY DIARRHEA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL PORCINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS ASSOCIATED DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL PORCINE VACCINES MARKET SIZE, BY PORCINE CIRCOVIRUS ASSOCIATED DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL PORCINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL PORCINE VACCINES MARKET SIZE, BY PORCINE REPRODUCTIVE & RESPIRATORY SYNDROME, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL PORCINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL PORCINE VACCINES MARKET SIZE, BY SWINE INFLUENZA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL PORCINE VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL PORCINE VACCINES MARKET SIZE, BY CONJUGATE VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL PORCINE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL PORCINE VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL PORCINE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL PORCINE VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL PORCINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL PORCINE VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL PORCINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL PORCINE VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL PORCINE VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL PORCINE VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL PORCINE VACCINES MARKET SIZE, BY HOG/PIG PRODUCTION FARM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL PORCINE VACCINES MARKET SIZE, BY HOG/PIG PRODUCTION FARM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL PORCINE VACCINES MARKET SIZE, BY VETERINARY CLINICS/HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL PORCINE VACCINES MARKET SIZE, BY VETERINARY CLINICS/HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES PORCINE VACCINES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 90. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 92. AUSTRALIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 95. CHINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 96. CHINA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 97. CHINA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 98. CHINA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 101. INDIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 102. INDIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 103. INDIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 104. INDIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 107. INDONESIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 108. INDONESIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 109. INDONESIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 110. INDONESIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 113. JAPAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 114. JAPAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 115. JAPAN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 116. JAPAN PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 119. MALAYSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 120. MALAYSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 121. MALAYSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 122. MALAYSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 126. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 128. PHILIPPINES PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 131. SINGAPORE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 132. SINGAPORE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 133. SINGAPORE PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 134. SINGAPORE PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 138. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 140. SOUTH KOREA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 143. TAIWAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 144. TAIWAN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 145. TAIWAN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 146. TAIWAN PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 149. THAILAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 150. THAILAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 151. THAILAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 152. THAILAND PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 155. VIETNAM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 156. VIETNAM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 157. VIETNAM PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 158. VIETNAM PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA PORCINE VACCINES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 169. DENMARK PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 170. DENMARK PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 171. DENMARK PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 172. DENMARK PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 175. EGYPT PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 176. EGYPT PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 177. EGYPT PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 178. EGYPT PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 181. FINLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 182. FINLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 183. FINLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 184. FINLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 187. FRANCE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 188. FRANCE PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 189. FRANCE PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 190. FRANCE PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 193. GERMANY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 194. GERMANY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 195. GERMANY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 196. GERMANY PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 199. ISRAEL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 200. ISRAEL PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 201. ISRAEL PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 202. ISRAEL PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 205. ITALY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 206. ITALY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 207. ITALY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 208. ITALY PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 212. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 213. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 214. NETHERLANDS PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 217. NIGERIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 218. NIGERIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 219. NIGERIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 220. NIGERIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 223. NORWAY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 224. NORWAY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 225. NORWAY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 226. NORWAY PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 229. POLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 230. POLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 231. POLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 232. POLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 235. QATAR PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 236. QATAR PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 237. QATAR PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 238. QATAR PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 241. RUSSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 242. RUSSIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 243. RUSSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 244. RUSSIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 248. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 249. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 250. SAUDI ARABIA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH AFRICA PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 259. SPAIN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 260. SPAIN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 261. SPAIN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 262. SPAIN PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 265. SWEDEN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 266. SWEDEN PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 267. SWEDEN PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 268. SWEDEN PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 272. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 273. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 274. SWITZERLAND PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 277. TURKEY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 278. TURKEY PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 279. TURKEY PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 280. TURKEY PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED ARAB EMIRATES PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 291. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 292. UNITED KINGDOM PORCINE VACCINES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 293. PORCINE VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 294. PORCINE VACCINES MARKET, FPNV POSITIONING MATRIX, 2023